MOMENCE, Ill.—Supplementing with Futureceuticals’ FruiteX-B® calcium fructoborate, along with a combination of glucosamine and chondroitin, provides more benefits to joint health and flexibility compared to glucosamine and chondroitin supplementation alone. (Journal of Aging Research & Clinical Practice. 2012; Online)

Outcome measures used in the study included the widely-used WOMAC and McGill questionnaires, standard indices of joint and flex comfort. 

In the two-week, double-blind, placebo-controlled study, subjects in the FruiteX-B, glucosamine, and chondroitin group experienced a 24-percent improvement in WOMAC scores and a 25-percent improvement in McGill scores. Subjects taking the glucosamine/chondroitin combination alone did not experience any significant improvements. Statistics were independently reviewed by the Department of Statistics, School of Information and Computer Science, University of California at Irvine.

"This study shows that in the context of the widely used combination of glucosamine and chondroitin, FruiteX-B continues to provide the significant benefits for joint health documented in previous research on this remarkable mineral complex," said Hartley Pond, the company's vice president of sales. "The results in the FruiteX-B, glucosamine and chondroitin group align with previous studies published earlier this year and in 2012. In all instances, FruiteX-B delivered significant, fast-acting improvement that people feel."

For more of the latest research on joint health, download INSIDER’s “Double-Jointed" Digital Pulse.